Abstract
The integration of genetic engineering into pharmacological research is transforming the landscape of precision medicine, offering the potential to revolutionize healthcare. Precision medicine focuses on tailoring treatments to individuals based on genetic, environmental, and lifestyle factors, moving beyond the traditional “one-size-fits-all” approach. This editorial highlights the pivotal role of genetic engineering in advancing precision medicine, exploring its applications in drug discovery, pharmacogenomics, and innovative therapies such as gene and cell treatments. Tools like CRISPR-Cas9 and advancements in omics technologies have accelerated the development of personalized therapies and enhanced our understanding of disease mechanisms. Despite these breakthroughs, challenges persist. Technical hurdles like off-target effects, ethical concerns surrounding germline editing, and the high costs of these technologies must be addressed. Opportunities, however, abound—ranging from artificial intelligence-driven innovations to collaborative research initiatives, which promise to streamline the development of genetic engineering applications. This convergence of disciplines is not only reshaping drug development but also expanding the therapeutic arsenal to tackle complex diseases. With sustained investment, interdisciplinary collaboration, and an emphasis on equitable access, the promise of precision medicine—treatments tailored to each individual’s genetic blueprint—is rapidly becoming a reality.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call